Charles River Laboratories (CRL) Misses Q1 EPS by 2c; Reaffirms Outlook
Tweet Send to a Friend
Charles River Laboratories (NYSE: CRL) reported Q1 EPS of $0.69, $0.02 worse than the analyst estimate of ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
